Merck (MRK) Announces First Clinical Outcomes Evaluating Six-Week Dosing Schedule for KEYTRUDA Presented at AACR

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/12/2026

1. CRWV
2. SMCI
3. LITE
4. ONON
5. CAVA
6. AMC
7. QNT
8. NCMI
9. FOCL
10. TME

Go back to Merck (MRK) Announces First Clinical Outcomes Evaluating Six-Week Dosing Schedule for KEYTRUDA Presented at AACR
Merck & Co. (NYSE: MRK) Delayed: 130.42 --0 (-0%)
Previous Close $130.42    52 Week High $65.46 
Open $130.42    52 Week Low $47.97 
Day High $130.42    P/E 88.72 
Day Low $130.42    EPS $1.47 
Volume 5,496